India, June 18 -- The question is no longer whether biotechnology is changing. It already has. The question is whether our universities are keeping pace. The biotechnology sector is in the throes of a fundamental transformation. Artificial intelligence (AI) and machine learning are no longer adjacent technologies-they are central to how modern biotech works. Drug discovery platforms use AI to screen molecular compounds in weeks instead of years. Diagnostic companies deploy deep learning models that rival human specialists. Gene therapies rely on computational tools for analysis. Precision medicine frameworks use genomic data at scale. These are not fringe innovations; they are the operating standard of the industry. DeepMind's AlphaFold h...